Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs
It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products.
According to the Ministry of Food and Drug Safety(MFDS), the collective number of pharmaceutical produ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
